Prospects of minimally invasive surgery in the treatment of primary open-angle glaucoma

The article examines the prospects of minimally invasive glaucoma surgery in the treatment of primary open-angle glaucoma. The primary focus is on the effectiveness and safety of contemporary minimally invasive glaucoma surgery techniques, such as iStent, MicroShunt, and Hydrus. The authors highlight the significant reduction in intraocular pressure and the decrease in dependence on medication therapy for most patients following these procedures. The article presents results from numerous clinical studies demonstrating the high effectiveness and safety of these methods. The uniqueness of this review lies in the comprehensive analysis of current data and the identification of key advantages of minimally invasive glaucoma surgery compared to traditional glaucoma treatment methods. The article also emphasizes the economic feasibility of minimally invasive glaucoma surgery, which can significantly reduce the burden on healthcare systems in various regions. The authors point out the necessity for further research to evaluate the long-term effectiveness and safety of these technologies, as well as to determine optimal management strategies for primary open-angle glaucoma in different population subgroups. Detailed meta-analyses and multicenter studies could contribute to better understanding of the mechanisms of action and potential limitations of these technologies, providing a basis for personalized approach to glaucoma treatment.